Personalized medicine

The individual patient is the most important determinant of therapeutic efficacy’ emphasized Hippocrates 2500 years ago. Nowadays, this emerging strategy is also implemented in the field of oncology. The molecular analysis of a patients tumor in combination with different public available genomic-drug related databases are likely to result in the identification of several “druggable” targets and potential therapeutic regimens for a specific patient. By screening a number of this anticancer agents in a PDX model, a selection of the most appropriate treatment approach can be made and administered to the donor patient. 

Trace PDX models

Search in our online database to find a relevant model that fits into your research pipeline. For more advice, contact us